OppenheimerFunds’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$60.3M Buy
1,214,580
+127,052
+12% +$5.72M 0.08% 267
2018
Q4
$39.3M Sell
1,087,528
-387,948
-26% -$16.2M 0.06% 332
2018
Q3
$75.3M Buy
1,475,476
+262,100
+22% +$11.6M 0.09% 248
2018
Q2
$44.9M Buy
1,213,376
+601,024
+98% +$22.9M 0.05% 350
2018
Q1
$23.1M Sell
612,352
-728
-0.1% -$25.7K 0.03% 535
2017
Q4
$19.9M Buy
613,080
+404
+0.1% +$12.8K 0.02% 587
2017
Q3
$18.5M Sell
612,676
-912
-0.1% -$27.1K 0.02% 590
2017
Q2
$18M Buy
613,588
+188
+0% +$5.14K 0.02% 587
2017
Q1
$15.6M Sell
613,400
-273,124
-31% -$7.05M 0.02% 653
2016
Q4
$22.8M Buy
+886,524
New +$23.3M 0.03% 540

Other funds holding TECH

OppenheimerFunds's TECH Position: Q1 2019 in Review

OppenheimerFunds increased its Bio-Techne (TECH) stake by 12% in Q1 2019, buying an estimated $5.72M and bringing the position to 1,214,580 shares worth $60.3M. The position accounts for 0.08% of the portfolio, ranked #267.

OppenheimerFunds first reported a position in TECH in Q4 2016 and has held it in 10 quarters since. The position peaked at $75.3M in Q3 2018. 356 funds tracked by Wall St. Rank hold TECH as of Q1 2019.

  • OppenheimerFunds held 1,214,580 shares of Bio-Techne worth $60.3M as of Q1 2019.
  • OppenheimerFunds bought 127,052 Bio-Techne shares in Q1 2019, an estimated $5.72M.
  • Bio-Techne made up 0.08% of OppenheimerFunds's portfolio in Q1 2019, its #267 holding.
  • OppenheimerFunds first reported a position in Bio-Techne in Q4 2016 and has held it in 10 quarters since.
  • OppenheimerFunds's Bio-Techne position peaked at $75.3M in Q3 2018.
  • 356 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.